Maha Dalal
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 6
- Tuberculosis Research and Epidemiology 1
-
- Biochemical and Molecular Research 4
- Co-authors
- David A. Cooney (10 shared papers)David G. Johns (9 shared papers)Samuel Broder (4 shared papers)Jan Balzarini (4 shared papers)Hiroaki Mitsuya (3 shared papers)Erik De Clercq (3 shared papers)Piet Herdewijn (2 shared papers)James B. McMahon (3 shared papers)
- Journals
- Biochemical Pharmacology (4 papers)Molecular Pharmacology (2 papers)Journal of Medicinal Chemistry (1 paper)Biochemical and Biophysical Research Communications (1 paper)International Journal of Drug Delivery Technology (1 paper)
- Partner nations
- United StatesMalaysiaUkraine
In The Last Decade
Maha Dalal
12 papers receiving 956 citations
Peers
Comparison fields: 5 of 61
- Virology 506
- Infectious Diseases 721
- Physiology 49
- Epidemiology 263
- Molecular Biology 402
Countries citing papers authored by Maha Dalal
This map shows the geographic impact of Maha Dalal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha Dalal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha Dalal more than expected).
Fields of papers citing papers by Maha Dalal
This network shows the impact of papers produced by Maha Dalal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha Dalal. The network helps show where Maha Dalal may publish in the future.
Co-authors
The 25 scholars most cited alongside Maha Dalal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 279 | |
| 2 | 1987 | 212 | |
| 3 | 1987 | 127 | |
| 4 | 1986 | 108 | |
| 5 | 1987 | 86 | |
| 6 | 1987 | 65 | |
| 7 | 1986 | 41 | |
| 8 | Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic properties. | 1986 | 24 |
| 9 | 1985 | 22 | |
| 10 | Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance. | 1986 | 17 |
| 11 | 1987 | 9 | |
| 12 | 2010 | 6 |
About Maha Dalal
Maha Dalal is a scholar working on Infectious Diseases, Molecular Biology, Immunology, Virology and Organic Chemistry, having authored 12 papers that have together received 996 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (6 papers), T-cell and Retrovirus Studies (4 papers), Biochemical and Molecular Research (4 papers), HIV Research and Treatment (3 papers), Click Chemistry and Applications (1 paper), Tuberculosis Research and Epidemiology (1 paper), Acute Lymphoblastic Leukemia research (1 paper) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Virology (506 citations), Infectious Diseases (721 citations), Physiology (49 citations), Epidemiology (263 citations) and Molecular Biology (402 citations). Maha Dalal has collaborated with scholars based in United States, Malaysia and Ukraine. Frequent co-authors include David A. Cooney, David G. Johns, Samuel Broder, Jan Balzarini, Hiroaki Mitsuya, Erik De Clercq, Piet Herdewijn, James B. McMahon, Mohan Nadkarni and Jan Balzarini. Their work appears in journals such as Biochemical Pharmacology, Molecular Pharmacology, Journal of Medicinal Chemistry, Biochemical and Biophysical Research Communications and International Journal of Drug Delivery Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.